Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 12Not yet recruiting 5Completed 4Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 542Neoplasms 381Carcinoma, Non-Small-Cell Lung 323Colorectal Neoplasms 296Lung Neoplasms 237Prostatic Neoplasms 220Carcinoma, Hepatocellular 212Stomach Neoplasms 155Pancreatic Neoplasms 155Leukemia, Myeloid, Acute 141Uterine Cervical Neoplasms 132Multiple Myeloma 130Recurrence 119Rectal Neoplasms 114Ovarian Neoplasms 109Neoplasm Metastasis 105Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 90Triple Negative Breast Neoplasms 86Esophageal Neoplasms 84Glioblastoma 81Endometrial Neoplasms 81Small Cell Lung Carcinoma 79Colonic Neoplasms 78Brain Neoplasms 77Melanoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Glioma 61Disease 60

Interventions

nimotuzumab 2surufatinib 1Hematologic Tests 1Gemcitabine 1Blood Specimen Collection 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic cancer, adult × Clear all
NCT07529626 2026-04-14

MIND-PANC

Shanghai Zhongshan Hospital

Not yet recruiting
320 enrolled
Gastrointestinal

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Not yet recruiting
106 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT07277452 2025-12-11

NOTABLE-309

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
156 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT06938503 2025-04-22

AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT06760741 2025-01-07

PREVENPANC

Hospital Clinic of Barcelona

Not yet recruiting
900 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic carcinoma, familial, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡